BACKGROUND AND AIMS: Volumetric laser endomicroscopy (VLE) is a new wide-field advanced imaging technology for Barrett's esophagus (BE). No data exist on incremental yield of dysplasia detection. Our aim is to report the incremental yield of dysplasia detection in BE using VLE. METHODS: This is a retrospective study from a prospectively maintained database from 2011 to 2017 comparing the dysplasia yield of 4 different surveillance strategies in an academic BE tertiary care referral center. The groups were (1) random biopsies (RB), (2) Seattle protocol random biopsies (SP), (3) VLE without laser marking (VLE), and (4) VLE with laser marking (VLEL). RESULTS: A total of 448 consecutive patients (79 RB, 95 SP, 168 VLE, and 106 VLEL) met the inclusion criteria. After adjusting for visible lesions, the total dysplasia yield was 5.7%, 19.6%, 24.8%, and 33.7%, respectively. When compared with just the SP group, the VLEL group had statistically higher rates of overall dysplasia yield (19.6% vs 33.7%, P = .03; odds ratio, 2.1, P = .03). Both the VLEL and VLE groups had statistically significant differences in neoplasia (high-grade dysplasia and intramucosal cancer) detection compared with the SP group (14% vs 1%, P = .001 and 11% vs 1%, P = .003). CONCLUSION: A surveillance strategy involving VLEL led to a statistically significant higher yield of dysplasia and neoplasia detection compared with a standard random biopsy protocol. These results support the use of VLEL for surveillance in BE in academic centers.
BACKGROUND AND AIMS: Volumetric laser endomicroscopy (VLE) is a new wide-field advanced imaging technology for Barrett's esophagus (BE). No data exist on incremental yield of dysplasia detection. Our aim is to report the incremental yield of dysplasia detection in BE using VLE. METHODS: This is a retrospective study from a prospectively maintained database from 2011 to 2017 comparing the dysplasia yield of 4 different surveillance strategies in an academic BE tertiary care referral center. The groups were (1) random biopsies (RB), (2) Seattle protocol random biopsies (SP), (3) VLE without laser marking (VLE), and (4) VLE with laser marking (VLEL). RESULTS: A total of 448 consecutive patients (79 RB, 95 SP, 168 VLE, and 106 VLEL) met the inclusion criteria. After adjusting for visible lesions, the total dysplasia yield was 5.7%, 19.6%, 24.8%, and 33.7%, respectively. When compared with just the SP group, the VLEL group had statistically higher rates of overall dysplasia yield (19.6% vs 33.7%, P = .03; odds ratio, 2.1, P = .03). Both the VLEL and VLE groups had statistically significant differences in neoplasia (high-grade dysplasia and intramucosal cancer) detection compared with the SP group (14% vs 1%, P = .001 and 11% vs 1%, P = .003). CONCLUSION: A surveillance strategy involving VLEL led to a statistically significant higher yield of dysplasia and neoplasia detection compared with a standard random biopsy protocol. These results support the use of VLEL for surveillance in BE in academic centers.
Authors: Osman O Ahsen; Kaicheng Liang; Hsiang-Chieh Lee; Michael G Giacomelli; Zhao Wang; Benjamin Potsaid; Marisa Figueiredo; Qin Huang; Vijaysekhar Jayaraman; James G Fujimoto; Hiroshi Mashimo Journal: Endoscopy Date: 2018-09-27 Impact factor: 10.093
Authors: Muhammad Aziz; Chandra S Dasari; Tarun Rai; Benjamin Alsop; Neil Gupta; Prashanth Vennalaganti; Viveksandeep Thoguluva Chandrasekar; Kelsey Able; Kevin Kennedy; Michael B Wallace; Kenneth K Wang; Herbert C Wolfsen; Prateek Sharma; Cadman L Leggett Journal: Transl Gastroenterol Hepatol Date: 2022-01-25
Authors: Theresa H Nguyen; Aaron P Thrift; Rollin George; Daniel G Rosen; Hashem B El-Serag; Gyanprakash A Ketwaroo Journal: Clin Gastroenterol Hepatol Date: 2021-04-08 Impact factor: 11.382
Authors: Yasmine Hussein Agha; Sachin Srinivasan; Jeffrey Hyder; Chelsea Wuthnow; Ali Taleb; Nathan Tofteland; William Kilgore; William Salyers Journal: Ann Gastroenterol Date: 2020-12-07
Authors: M S Smith; B Cash; V Konda; A J Trindade; S Gordon; S DeMeester; V Joshi; D Diehl; E Ganguly; H Mashimo; S Singh; B Jobe; M McKinley; M Wallace; Y Komatsu; S Thakkar; F Schnoll-Sussman; R Sharaiha; M Kahaleh; P Tarnasky; H Wolfsen; R Hawes; J Lipham; H Khara; D Pleskow; U Navaneethan; P Kedia; M Hasan; A Sethi; J Samarasena; U D Siddiqui; F Gress; R Rodriguez; C Lee; T Gonda; I Waxman; S Hyder; J Poneros; K Sharzehi; J A Di Palma; D V Sejpal; D Oh; J Hagen; R Rothstein; M Sawhney; T Berzin; Z Malik; K Chang Journal: Dis Esophagus Date: 2019-11-13 Impact factor: 2.822
Authors: Kara L Raphael; Molly Stewart; Divyesh V Sejpal; Mary Cheung; Matthew J Whitson; Dennis Han; Petros C Benias; Calvin Lee; Larry S Miller; Arvind J Trindade Journal: Clin Transl Gastroenterol Date: 2019-12 Impact factor: 4.488